Ethnic disparities in the pharmacologic characteristics of tacrolimus in heart transplantation

Transplantation Proceedings

Volumn 33, Issue 1-2, 2001, Pages 1581-1582

  Uber, P A ^a   Mehra, M R ^a,b   Scott, R L ^a   Prasad, A K ^a   Park, M H ^a  

^a OCHSNER MEDICAL CENTER   (United States)

^b BH 326 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; CYTOCHROME P450 3A4; KETOCONAZOLE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; TACROLIMUS;

ADULT; CAUCASIAN; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG METABOLISM; ETHNIC DIFFERENCE; HEART TRANSPLANTATION; HUMAN; NEGRO; PHARMACOGENETICS; PRIORITY JOURNAL;

ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; BODY WEIGHT; EUROPEAN CONTINENTAL ANCESTRY GROUP; HEART TRANSPLANTATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MULTIVARIATE ANALYSIS; PROSPECTIVE STUDIES; TACROLIMUS; TIME FACTORS;

EID: 0035081186     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0041-1345(00)02601-4     Document Type: Conference Paper

References (5)

1. Neylan JF: Transplantation 65:515, 1998
2. Andrews PA, Sen M, Chang RW: Lancet 348:1446, 1996
3. Floren LC, Bekersky I, Benet LZ, et al: Clin Pharmacol Ther 62:41, 1997
4. Abernathy DR, Flockhart DA: Circulation 101:1749, 2000
5. Rodriguez I, Abernathy DR, Woosley RL: Circulation 99:472, 1999